Shilpa received approval for Molshil? Oral Thin Films after sufficiently complying bioequivalence requirements.
Shilpas Paracetamol Oral Thin Films are patent protected and are first of this kind in the world.
The new presentation of Paracetamol from Shilpa will have benefits of easy administration, excellent palatability and overcome disadvantages of presently available pediatric formulations like dose variation, sedimentation or poor suspendability, presence of alcohol, messy and crystallized bottles in usage, fragile glass bottles etc.
Powered by Capital Market - Live News